Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes
The Effect of Accumulated Versus Traditional Exercise Training on Metabolic Control and Heart Function in Individuals With Type 2 Diabetes
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will compare two interventions with the same exercise intensities and caloric expenditure but with different exercise frequency, on metabolic control and other risk factors in individuals with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
March 9, 2015
CompletedFirst Posted
Study publicly available on registry
March 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedNovember 6, 2015
November 1, 2015
1 year
March 9, 2015
November 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
glycosylated hemoglobin (HbA1c)
The measured HbA1c level consists of average blood glucose by 50% from the last month, 25% from the previous month, and 25% by the two first previous months. Analysis: standard procedure of St Olavs Hospital.
12 weeks
Study Arms (2)
accumulated exercise
EXPERIMENTAL12 exercise sessions of 10 minutes each week, 2 per day, 1 day rest
traditional exercise
ACTIVE COMPARATOR4 exercise sessions of 30 minutes each week, 3 in the training laboratory, 1 at home.
Interventions
Eligibility Criteria
You may qualify if:
- type 2 diabetes
You may not qualify if:
- insulin treatment
- severe chronic diabetic complications
- liver dysfunction
- kidney dysfunction
- inflammatory diseases
- heart failure
- myocardial ischemia
- major cardiovascular event history
- physical exercise more than current guidelines for type 2 diabetes
- inability to exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Circulation and Diagnostic Imaging
Trondheim, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charlotte Ingul, PhD MD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2015
First Posted
March 13, 2015
Study Start
October 1, 2014
Primary Completion
October 1, 2015
Study Completion
November 1, 2015
Last Updated
November 6, 2015
Record last verified: 2015-11